Inventor
ROEHL INGO
DE18 patents
⚠️ This page may combine multiple inventors who share the name “ROEHL INGO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALNYLAM PHARMACEUTICALS INC
5 patentsUS7749978B2Jul 6, 2010
Compositions and methods for inhibiting expression of Huntingtin gene
ALNYLAM PHARMACEUTICALS INC113 citations99
US7320965B2Jan 22, 2008
Compositions and methods for inhibiting expression of Huntingtin gene
ALNYLAM PHARMACEUTICALS INC208 citations99
US7582745B2Sep 1, 2009
Compositions and methods for inhibiting expression of Nav1.8 gene
ALNYLAM PHARMACEUTICALS INC152 citations98
US7928217B2Apr 19, 2011
Nuclease resistant double-stranded ribonucleic acid
ALNYLAM PHARMACEUTICALS INC37 citations92
US7902168B2Mar 8, 2011
Compositions and methods for inhibiting expression of Nav1.8 gene
ALNYLAM PHARMACEUTICALS INC1 citations52
ROZEMA DAVID B
3 patentsUS8501930B2Aug 6, 2013
Peptide-based in vivo siRNA delivery system
ROZEMA DAVID B180 citations98
US8426554B2Apr 23, 2013
In vivo polynucleotide delivery conjugates having enzyme sensitive linkages
ROZEMA DAVID B47 citations97
US8802773B2Aug 12, 2014
In vivo polynucleotide delivery conjugates having enzyme sensitive linkages
ROZEMA DAVID B12 citations92
HOFFMANN LA ROCHE
3 patentsUS9968647B2May 15, 2018
Small molecule conjugates for intracellular delivery of biologically active compounds
HOFFMANN LA ROCHE1 citations62
US9301990B2Apr 5, 2016
Small molecule conjugates for intracellular delivery of biologically active compounds
HOFFMANN LA ROCHE2 citations62
US9198947B2Dec 1, 2015
Small molecule conjugates for intracellular delivery of nucleic acids
HOFFMANN LA ROCHE1 citations62